A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
Clinical trial NCT05217810 · RECRUITING
Trial details
- NCT number
- NCT05217810
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-09
- Primary completion
- 2026-12-23
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.